Chinese Wuhan Virus Thread

South block

Member
Sep 22, 2018
56
44
India
They used to give me two steroid injection daily through canuala during my hospital stay. My discharge medicine include 1 month course of steroid and i took the medicine for next one week. When i was admitted again in hospital after a week, one of the senior most pulmonologist after checking what medicine i was taking.. immediately asked me to stop taking steroids. Now i know the reason lol.
 

Sathya

Senior member
Dec 2, 2017
2,155
1,177
India
Yesterday got a news from a friend
That in his night duty number of death s were 15 in a floor at the rate of 1/ 30 mins.

Out of which only 1 accounted in Covid death,
Rest 14 in SARI ( severe acute respiratory illness) case.

@Falcon
 

TARGET

Well-Known member
Dec 2, 2017
485
384
Yesterday got a news from a friend
That in his night duty number of death s were 15 in a floor at the rate of 1/ 30 mins.

Out of which only 1 accounted in Covid death,
Rest 14 in SARI ( severe acute respiratory illness) case.

@Falcon
Identifying Covid related death will be an issue for both state and center-level orphan relief packages. Every state should identify the actual covid death case so that more people can take these benefits.
 
  • Agree
Reactions: randomradio

Sathya

Senior member
Dec 2, 2017
2,155
1,177
India
Identifying Covid related death will be an issue for both state and center-level orphan relief packages. Every state should identify the actual covid death case so that more people can take these benefits.
It's going to be a big mess. since swab results were made negative.
Even those covid warriors who worked there were not exempt.
 

randomradio

Senior Member
Nov 30, 2017
10,600
8,032
India
Good news for Bangalore and India in general. More than 7000 hospitals beds are free out of 13000+ beds. Case numbers have dropped to 5000+ per day.
 

STEPHEN COHEN

Senior member
Dec 4, 2017
6,249
3,831
Good news for Bangalore and India in general. More than 7000 hospitals beds are free out of 13000+ beds. Case numbers have dropped to 5000+ per day.

At least 15 more days before we can say that 2nd wave is over

We need new cases to come down to maximum 1 lakh per day
 

RISING SUN

Senior member
Dec 3, 2017
8,435
4,327

Wockhardt offers to make 2 billion Covid vaccine doses a year​

Indian pharmaceutical company Wockhardt has told the government it can produce as many as two billion doses a year of most Covid-19 vaccines, starting with a capacity of 500 million doses by February 2022.

In a formal submission to the Centre earlier this month, Mumbai-based Wockhardt has sought help to identify potential partners in the country whose vaccines it could produce, The Indian Express has learnt. It is also in the process of “accessing” some of the technology to make Covid-19 vaccines. It has told the government it has the manufacturing and research capability to create a diversified portfolio that would allow it to produce and supply mRNA, protein-based and viral vector-based vaccines.

The government is examining the company’s offer. Queries to Wockhardt remained unanswered by press time Tuesday.

In a recent presentation at a seminar organised by Swadeshi Jagran Manch, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya had said, “Wockhardt had last week told us it also wants to tie up with any company (for manufacturing Covid-19 vaccines). So, we are also working on that. We will get them tied up with one of the companies.”

A quick plan to ramp up
The government has an opportunity to not only diversify its short-term supply of vaccines by using capacities of companies like Wockhardt, but also secure access to vaccines in the long term.

Outside of India, Wockhardt already has an agreement with the UK government to “fill and finish” Covid-19 vaccines exclusively for the UK. So far, it has been using its plant in North Wales to fill the AstraZeneca-Oxford University vaccine into vials and package them for use in the country’s immunisation programme. As per the agreement, its capacity will be used for other Covid-19 vaccines the UK government requires it to fill and finish.

The development is crucial, as India has been struggling to meet its requirement for vaccines to cover its population — a problem that has pushed companies like Serum Institute of India (SII) and Bharat Biotech to even repurpose their capacities to make other life-saving vaccines.

Wockhardt does not plan to manufacture Bharat Biotech’s Covaxin at this time, given the specific requirements of a Biosafety Level 3 (BSL 3) facility and the longer output time.

“The idea is not to make two billion doses of a single vaccine, but to have 2-3 vaccines available so that there is a more sustainable activity,” a source close to the development said on condition of anonymity.

Wockhardt is planning to “quickly” establish the capacity to make 500 million doses a year of “any” Covid-19 vaccine using these platforms. It would take around six to nine months to set up this capacity. Talks are on with several firms, and an agreement with an international company is likely “in the next few weeks”, the source said.
 

randomradio

Senior Member
Nov 30, 2017
10,600
8,032
India

Wockhardt offers to make 2 billion Covid vaccine doses a year​

Indian pharmaceutical company Wockhardt has told the government it can produce as many as two billion doses a year of most Covid-19 vaccines, starting with a capacity of 500 million doses by February 2022.

In a formal submission to the Centre earlier this month, Mumbai-based Wockhardt has sought help to identify potential partners in the country whose vaccines it could produce, The Indian Express has learnt. It is also in the process of “accessing” some of the technology to make Covid-19 vaccines. It has told the government it has the manufacturing and research capability to create a diversified portfolio that would allow it to produce and supply mRNA, protein-based and viral vector-based vaccines.

The government is examining the company’s offer. Queries to Wockhardt remained unanswered by press time Tuesday.

In a recent presentation at a seminar organised by Swadeshi Jagran Manch, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya had said, “Wockhardt had last week told us it also wants to tie up with any company (for manufacturing Covid-19 vaccines). So, we are also working on that. We will get them tied up with one of the companies.”

A quick plan to ramp up
The government has an opportunity to not only diversify its short-term supply of vaccines by using capacities of companies like Wockhardt, but also secure access to vaccines in the long term.

Outside of India, Wockhardt already has an agreement with the UK government to “fill and finish” Covid-19 vaccines exclusively for the UK. So far, it has been using its plant in North Wales to fill the AstraZeneca-Oxford University vaccine into vials and package them for use in the country’s immunisation programme. As per the agreement, its capacity will be used for other Covid-19 vaccines the UK government requires it to fill and finish.

The development is crucial, as India has been struggling to meet its requirement for vaccines to cover its population — a problem that has pushed companies like Serum Institute of India (SII) and Bharat Biotech to even repurpose their capacities to make other life-saving vaccines.

Wockhardt does not plan to manufacture Bharat Biotech’s Covaxin at this time, given the specific requirements of a Biosafety Level 3 (BSL 3) facility and the longer output time.

“The idea is not to make two billion doses of a single vaccine, but to have 2-3 vaccines available so that there is a more sustainable activity,” a source close to the development said on condition of anonymity.

Wockhardt is planning to “quickly” establish the capacity to make 500 million doses a year of “any” Covid-19 vaccine using these platforms. It would take around six to nine months to set up this capacity. Talks are on with several firms, and an agreement with an international company is likely “in the next few weeks”, the source said.

From Feb is going to be pointless for India. Studies indicate the vaccinations are going to provide long term immunity.

 

randomradio

Senior Member
Nov 30, 2017
10,600
8,032
India
As of 10 days ago, Bangalore had administered 26% of the population with the 1st dose and 7% with the second dose.

BBMP claims they will now consistently provide vac at 1L per day or higher. So at least 3 million more will be covered by the end of the month with 1st dose. That will take us to a 60% coverage, maybe 70% if they push it a bit more. That's most of our adult population.

But with a ridiculous 84-day wait period for the second dose of Covishield, it will take us until Oct for the entire 60-70% to be fully protected.